Defining the Profile of LF Antibody Reactivity following MDA

Review status: 
Accepted

Research question

Determine age-specific prevalence of LF Antibody following MDA to inform surveillance strategies.

Study sites

This study is Completed

Contact

Pat Lammie
plammie@taskforce.org

Lead institution(s)

Institut Louis Malarde

Other collaborator(s)

World Health Organization (WHO)
Neglected Tropical Diseases Support Center (NTD-SC)
Centers for Disease Control and Prevention (CDC)
Smith College

Funding partner(s)

Bill & Melinda Gates Foundation

Reference information

NTD-SC #
48
Completed on

Tags

Disease(s)
Lymphatic filariasis
Research topic(s)
Surveillance
Elimination as a public health problem
Elimination of transmission
Diagnostics
Evaluation
Monitoring
Serology
Study design(s)
Cross-sectional
Indicator(s)
Prevalence